期刊文献+

5-氮-2′-脱氧胞苷联合曲古抑菌素A对人肺腺癌细胞株A549增殖和凋亡的影响 被引量:2

Effect of 5-aza-2-deoxycytidine and trichostatin A on proliferation and apoptosis of lung epithelial carcinoma A549 cells
下载PDF
导出
摘要 目的探讨DNA甲基化转移酶抑制剂5-氮-2′-脱氧胞苷(5-aza-dC)联合组蛋白去乙酰化抑制剂曲古抑菌素A(TSA)对人肺腺癌细胞株A549增殖和凋亡的影响。方法人肺腺癌细胞株A549细胞用含10%胎牛血清的DMEM培养液培养。实验分4组,5-aza-dC组:细胞接种20h后,加入5μmol/L的5-aza-dC;TSA组:细胞接种20h后,加入300nmol/LTSA;5-aza-dC+TSA组:细胞接种20h后,加入5μmol/L5-aza-dC,24h后再加入300nmol/L TSA;对照组:DMEM培养液中加入等量的二甲基亚砜(DMSO)。MTT比色法测定各处理因素对A549细胞生长的影响;Annexin V/PI双染法测定各组细胞培养72h后的凋亡情况;应用RT-PCR检测各组细胞培养72h后细胞CCAAT增强子启动蛋白α(C/EBPα)mRNA的表达。结果 (1)5-aza-dC及TSA呈时间依赖性地抑制A549细胞的生长,而在同一时间不同组别比较联合用药组细胞生长抑制率较单用药组明显增加[12h:35.51%vs21.63%,19.59%;24h:43.19%vs32.39%,30.60%;36h:54.85%vs38.83%,37.35%;48h:60.69%vs45.79%,43.84%;60h:68.92%vs50.60%,50.20%;72h:74.54%vs59.23%,57.82,P<0.05];(2)5-aza-dC和TSA能够诱导A549细胞凋亡,且联合用药组A549细胞凋亡率(75.35±1.46)%明显高于5-aza-dC(49.76±1.32)%(P<0.05)和TSA组(50.88±1.06)%(P<0.05);(3)5-aza-dC和TSA能够上调C/EBPαmRNA的表达,联合用药组中C/EBPαmRNA表达量(0.581±0.024)明显高于5-aza-dC组(0.402±0.016)(P<0.05)和TSA组(0.394±0.031)(P<0.05),有统计学意义;(4)5-aza-dC组与TSA组在抑制A549细胞生长、诱导细胞凋亡、增强C/EBPαmRNA的表达方面比较,差别均无统计学意义(P>0.05)。结论与单用5-aza-dC或TSA相比,联合应用两种药物能够更好的抑制人肺腺癌A549细胞的增殖、诱导细胞凋亡和增强C/EBPα基因mRNA的表达。 Objective To study the effect of methyltransferase inhibitor 5-aza-2-deoxycytidine (5-aza-dC) and histone deacetylase inhibitor trichostatin A (TSA) on proliferation and apoptosis of lung epithelial carcinoma A549 cells. Methods Human epithelial carcinoma A549 cells cultured in DMEM containing 10% fetal bovine serum were divided into control group,5-aza-dC group,TSA group,and 5-aza-dC +TSA group. Dimethyl sulfoxide (DMSO) was added into DMEM for control group. A549 cells were treated with 5 μmol/L 5-aza-dC and 300 nmol/L TSA 20 h after inoculation in 5-aza-dC group and TSA group,while A549 cells were treated with 5 μmol/L 5-Aza-CdR 20 h after inoculation and 300 nmol/L TSA after 24 h after inoculation in 5-aza-dC +TSA group. Effects of various processing factors on growth and apoptosis of A549 cells were detected by MTT assay with Annexin V/PI double staining 72 h after inoculation. Expression of CCAAT/enhancer-binding protein-a (C/EBPα) mRNA in different groups was detected by RT-PCR 72 h after inoculation. Results 5-aza-dC and TSA inhibited the growth of A549 cells in a time-dependent manner. The cell growth inhibitory rate was significantly higher in combination group than in single drug group (P0.05). 5-aza-dC and TSA induced the apoptosis of A549 cells. The apoptotic rate of A549 cells was significantly higher in the combined treatment group than in single drug treatment group (P0.05). The expression level of C/EBPα mRNA was significantly higher in combination group (0.581±0.024) than in 5-Aza-CdR group (0.402±0.016) and TSA group (0.394±0.031) after treatment with 5-aza-dC and TSA (P0.05). No significant difference was found in growth and apoptosis of A549 cells,and in expression of C/EBPα mRNA between 5-aza-dC group and TSA group. Conclusion Combined 5-aza-CdR and TSA can more significantly inhibit the proliferation and induce the apoptosis of A549 cells,and increase the expression of C/EBPα mRNA than 5-aza-CdR or TSA alone,thus laying a theoretical basi
出处 《第三军医大学学报》 CAS CSCD 北大核心 2010年第17期1857-1860,共4页 Journal of Third Military Medical University
基金 江西省科技支撑计划项目(837)~~
关键词 肺肿瘤 曲古抑菌素A 5-氮-2′-脱氧胞苷 C/EBPΑ 甲基化 A549细胞 lung tumor trichostatin A 5-aza-2-deoxycytidine C/EBPα methylation A549 cell
  • 相关文献

参考文献17

  • 1Wingo P A, Ries L A, Gioviuo G A, et al. Annual report to thenation on the status of cancer, 1973-1996, with a special sectiononlung cancer andtobacco smoking [ J]. Natl CaneerInst, 1999, 91 (8) : 675 - 690. 被引量:1
  • 2Momparler R L. Cancer epigenetics [ J ]. Oncogene, 2003, 22 (42) : 6479 - 6483. 被引量:1
  • 3Miremadi A, Oestergaard M Z, Pharoah P D, et al. Cancer gentics of epigenetic genes[ J 1. Hum Mol Genet, 2007, 16 ( 1 ) : R28 - Rd9. 被引量:1
  • 4Bird A, DNA methylation patters and epigeneticmemory [ J] . Genes Dev, 2002, 16(1): 6-21. 被引量:1
  • 5Boland C R, Shin S K, Goel A. promoter methylation in the genesis of gastrointestinal cancer[ J ]. Yonsei Med, 200950 (3) : 309 - 321. 被引量:1
  • 6Zhu W G, The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells[J].Curr Med Chem Anticancer Aqents 2003, 3 (3) : 187 - 199. 被引量:1
  • 7董必文,段凤英.5-aza-dC、TSA联合MeCP2的RNA干扰质粒对人肺腺癌细胞株A549生物学行为的影响[J].实验与检验医学,2010,28(2):110-113. 被引量:1
  • 8Peter A J, Daiya T. The role of DNA methylation in mammalian epigenetics[J]. Science, 2001, 293(5532) : 1068 - 1070. 被引量:1
  • 9Ghoshal K, Bai S. DNA methyltransferases as targets for cancer theraph[J].Drugs Today (Bare), 2007, 43(6) : 395 -422. 被引量:1
  • 10Oyer JA, , Aberrant epigenetic silencing is triggered by a transient reduction in gene expression[J]. PLoS One, 2009, 4(3) : e4832. 被引量:1

二级参考文献26

  • 1余祖滨,白莉,闵家新,姚珂,张国强.SOCS3基因转染对肺腺癌细胞株A549原癌基因c-fos、c-jun mRNA表达及细胞增殖的影响[J].第三军医大学学报,2004,26(17):1549-1552. 被引量:5
  • 2Aggarwal B B,Sethi G,Ahn K S,et al.Targeting signal-transducerand-activator-of-transcription-3 for prevention and therapy of cancer:modern target but ancient solution[J].Ann N Y Acad Sci,2006,1091:151-169. 被引量:1
  • 3Wormald S,Hilton D J.Inhibitors of cytokine signal transduction[J].J Biol Chem,2004,279(2):821 -824. 被引量:1
  • 4He B,You L,Uematsu K,et al.SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer[J].Proc Natl Acad Sci U S A,2003,100(24):14133-14138. 被引量:1
  • 5Ni Z,Lou W,Lee S O,et al.Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma[J].J Urol,2002,167(4):1859 -1862. 被引量:1
  • 6Huang M,Page C,Reynolds R K,et al.Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells[J].Gynecol Oncol,2000,79 (1):67-73. 被引量:1
  • 7Kube D,Holtick U,Vockerodt M,et al.STAT3 is constitutively activated in Hodgkin cell lines[J].Blood,2001,98(3):762 -770. 被引量:1
  • 8Mukohara T,Kudoh S,Yamauchi S,et al.Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC)[J].Lung Cancer,2003,41(2):123 -130. 被引量:1
  • 9Deng J,Grande F,Neamati N.Small molecule inhibitors of Stat3 signaling pathway[J].Curr Cancer Drug Targets,2007,7(1):91 -107. 被引量:1
  • 10Tokita T,Maesawa C,Kimura T,et al.Methylation status of the SOCS3 gene in human malignant melanomas[J].Int J Oncol,2007,30(3):689 -694. 被引量:1

共引文献5

同被引文献19

  • 1Hu H, Liu J, Yao L, et al. Real-time bioluminescence and tomographic imaging of gastric cancer in a novel orthotopic mouse model [J]. Oncol Rep, 2012, 27(6): 1937 -1943. 被引量:1
  • 2de-Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors[J]. Gastroenterol Clin North Am, 2013, 42(2): 219- 240. 被引量:1
  • 3Rodr guez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology [Jl. Nat Med, 2011, 17 (3) : 330 - 339. 被引量:1
  • 4Chao X, ZaoJ, Xiao-YiG, etal. BlockingofPI3K/AKTinducesap- optosis by its effect on NF -KB activity in gastric carcinoma cell line SGC7901 [J]. Biomed Pharmacother, 2010, 64(9) : 600 -604. 被引量:1
  • 5Long Y M, YeS, Rong J, et al. Nuclear factor kappa B: a marker of chemotherapy for human stage N gastric carcinoma [J]. World J Gastroenterol, 2008, 14(30): 4739 -4744. 被引量:1
  • 6Lu R, Gao X, Chen Y, et al. Association of an NFKBI intron SNP (rs4648068) with gastric cancer patients in the Han Chinese population[J]. BMC Gastroenterol, 2012, 12: 87. 被引量:1
  • 7Oue N, Hamai Y, Mitani Y, et al. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression [J]. Cancer Res, 2004, 64 (7) : 2397 - 2405. 被引量:1
  • 8Kantarjian H, Oki Y, Garcia-Manero G, et al. Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia [J] . Blood, 2007, 109(1) : 52 - 57. 被引量:1
  • 9Qu Z, Yan P, Fu 1, et al. DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic targe[J]. Cancer Res, 2010, 70(5): 1766- 1772. 被引量:1
  • 10Giacinti L, Giacinti C, Gabellini C, et al. Scriptaid effects on breast cancer oell Iines[J]. J Cell Physiol, 2012, 227(10): 3426 -3433. 被引量:1

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部